Glucotrack (GCTK) Long-Term Deferred Tax (2017 - 2021)

Glucotrack (GCTK) has 4 years of Long-Term Deferred Tax data on file, last reported at $11.7 million in Q4 2021.

• Quarterly Long-Term Deferred Tax rose 7.03% year-over-year to $11.7 million in Q4 2021, while the trailing twelve-month figure through Dec 2021 was $11.7 million (up 7.03% YoY) and the FY2021 annual result came in at $11.7 million, up 7.03% from the prior year.
• Long-Term Deferred Tax improved to $11.7 million in Q4 2021, from $10.9 million in the prior quarter.
• In the past five years, Long-Term Deferred Tax ranged from a high of $11.7 million in Q4 2021 to a low of $8.9 million in Q4 2018.
• A 4-year average of $10.5 million and a median of $10.6 million in 2017 frame the typical range for Long-Term Deferred Tax.
• Annual changes were most pronounced in 2018 — Long-Term Deferred Tax dropped 13.8% — and 2021, when it gained 7.03%.
• Tracing GCTK's Long-Term Deferred Tax over 4 years: stood at $10.4 million in 2017, then retreated by 13.8% to $8.9 million in 2018, then advanced by 22.0% to $10.9 million in 2020, then increased by 7.03% to $11.7 million in 2021.
• The last three Long-Term Deferred Tax figures came in at $11.7 million (Q4 2021), $10.9 million (Q4 2020), and $8.9 million (Q4 2018), per Business Quant data.